nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Teniposide—lymphatic system cancer	0.204	0.367	CbGbCtD
Oxybutynin—CYP3A5—Vincristine—lymphatic system cancer	0.0982	0.176	CbGbCtD
Oxybutynin—CYP3A4—Cytarabine—lymphatic system cancer	0.0808	0.145	CbGbCtD
Oxybutynin—CYP3A4—Teniposide—lymphatic system cancer	0.0796	0.143	CbGbCtD
Oxybutynin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0557	0.1	CbGbCtD
Oxybutynin—CYP3A4—Vincristine—lymphatic system cancer	0.0383	0.0688	CbGbCtD
Oxybutynin—Oedema peripheral—Carmustine—lymphatic system cancer	0.00125	0.00282	CcSEcCtD
Oxybutynin—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00125	0.00282	CcSEcCtD
Oxybutynin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00124	0.0028	CcSEcCtD
Oxybutynin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00123	0.00278	CcSEcCtD
Oxybutynin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00123	0.00277	CcSEcCtD
Oxybutynin—Visual impairment—Carmustine—lymphatic system cancer	0.00122	0.00276	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00122	0.00275	CcSEcCtD
Oxybutynin—Fatigue—Fludarabine—lymphatic system cancer	0.00122	0.00274	CcSEcCtD
Oxybutynin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00121	0.00272	CcSEcCtD
Oxybutynin—Hallucination—Vincristine—lymphatic system cancer	0.00121	0.00272	CcSEcCtD
Oxybutynin—Constipation—Fludarabine—lymphatic system cancer	0.00121	0.00272	CcSEcCtD
Oxybutynin—Pain—Fludarabine—lymphatic system cancer	0.00121	0.00272	CcSEcCtD
Oxybutynin—Urinary tract disorder—Vincristine—lymphatic system cancer	0.0012	0.0027	CcSEcCtD
Oxybutynin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00119	0.00269	CcSEcCtD
Oxybutynin—Urethral disorder—Vincristine—lymphatic system cancer	0.00119	0.00268	CcSEcCtD
Oxybutynin—Eye disorder—Carmustine—lymphatic system cancer	0.00119	0.00268	CcSEcCtD
Oxybutynin—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00118	0.00267	CcSEcCtD
Oxybutynin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00118	0.00267	CcSEcCtD
Oxybutynin—Flushing—Carmustine—lymphatic system cancer	0.00118	0.00266	CcSEcCtD
Oxybutynin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00118	0.00265	CcSEcCtD
Oxybutynin—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00117	0.00264	CcSEcCtD
Oxybutynin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00116	0.00262	CcSEcCtD
Oxybutynin—Asthenia—Teniposide—lymphatic system cancer	0.00115	0.0026	CcSEcCtD
Oxybutynin—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.00114	0.00258	CcSEcCtD
Oxybutynin—Melaena—Methotrexate—lymphatic system cancer	0.00114	0.00258	CcSEcCtD
Oxybutynin—Malaise—Bleomycin—lymphatic system cancer	0.00114	0.00258	CcSEcCtD
Oxybutynin—Pruritus—Teniposide—lymphatic system cancer	0.00114	0.00256	CcSEcCtD
Oxybutynin—Arrhythmia—Carmustine—lymphatic system cancer	0.00113	0.00256	CcSEcCtD
Oxybutynin—Cystitis—Methotrexate—lymphatic system cancer	0.00113	0.00255	CcSEcCtD
Oxybutynin—Cardiac disorder—Vincristine—lymphatic system cancer	0.00113	0.00254	CcSEcCtD
Oxybutynin—Mental disorder—Carmustine—lymphatic system cancer	0.00111	0.00251	CcSEcCtD
Oxybutynin—Erythema—Carmustine—lymphatic system cancer	0.00111	0.0025	CcSEcCtD
Oxybutynin—Malnutrition—Carmustine—lymphatic system cancer	0.00111	0.0025	CcSEcCtD
Oxybutynin—Cough—Bleomycin—lymphatic system cancer	0.00111	0.00249	CcSEcCtD
Oxybutynin—Angiopathy—Vincristine—lymphatic system cancer	0.0011	0.00248	CcSEcCtD
Oxybutynin—Diarrhoea—Teniposide—lymphatic system cancer	0.0011	0.00248	CcSEcCtD
Oxybutynin—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00109	0.00247	CcSEcCtD
Oxybutynin—Chest pain—Bleomycin—lymphatic system cancer	0.00108	0.00243	CcSEcCtD
Oxybutynin—Back pain—Carmustine—lymphatic system cancer	0.00107	0.00241	CcSEcCtD
Oxybutynin—Discomfort—Bleomycin—lymphatic system cancer	0.00107	0.0024	CcSEcCtD
Oxybutynin—Mental disorder—Vincristine—lymphatic system cancer	0.00106	0.0024	CcSEcCtD
Oxybutynin—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00106	0.00239	CcSEcCtD
Oxybutynin—Bladder pain—Methotrexate—lymphatic system cancer	0.00106	0.00239	CcSEcCtD
Oxybutynin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00106	0.00238	CcSEcCtD
Oxybutynin—Confusional state—Bleomycin—lymphatic system cancer	0.00104	0.00235	CcSEcCtD
Oxybutynin—Vision blurred—Carmustine—lymphatic system cancer	0.00104	0.00235	CcSEcCtD
Oxybutynin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00104	0.00234	CcSEcCtD
Oxybutynin—Oedema—Bleomycin—lymphatic system cancer	0.00103	0.00233	CcSEcCtD
Oxybutynin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00103	0.00233	CcSEcCtD
Oxybutynin—Erythema—Mitoxantrone—lymphatic system cancer	0.00103	0.00232	CcSEcCtD
Oxybutynin—Infection—Bleomycin—lymphatic system cancer	0.00103	0.00232	CcSEcCtD
Oxybutynin—Back pain—Vincristine—lymphatic system cancer	0.00102	0.0023	CcSEcCtD
Oxybutynin—Vomiting—Teniposide—lymphatic system cancer	0.00102	0.0023	CcSEcCtD
Oxybutynin—Agitation—Carmustine—lymphatic system cancer	0.00102	0.00229	CcSEcCtD
Oxybutynin—Asthenia—Fludarabine—lymphatic system cancer	0.00101	0.00228	CcSEcCtD
Oxybutynin—Rash—Teniposide—lymphatic system cancer	0.00101	0.00228	CcSEcCtD
Oxybutynin—Dermatitis—Teniposide—lymphatic system cancer	0.00101	0.00228	CcSEcCtD
Oxybutynin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00101	0.00227	CcSEcCtD
Oxybutynin—Headache—Teniposide—lymphatic system cancer	0.00101	0.00227	CcSEcCtD
Oxybutynin—Pruritus—Fludarabine—lymphatic system cancer	0.000998	0.00225	CcSEcCtD
Oxybutynin—Back pain—Mitoxantrone—lymphatic system cancer	0.000994	0.00224	CcSEcCtD
Oxybutynin—Anorexia—Bleomycin—lymphatic system cancer	0.000986	0.00222	CcSEcCtD
Oxybutynin—Agitation—Vincristine—lymphatic system cancer	0.00097	0.00219	CcSEcCtD
Oxybutynin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000969	0.00219	CcSEcCtD
Oxybutynin—Hypotension—Bleomycin—lymphatic system cancer	0.000966	0.00218	CcSEcCtD
Oxybutynin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000965	0.00218	CcSEcCtD
Oxybutynin—Convulsion—Carmustine—lymphatic system cancer	0.000958	0.00216	CcSEcCtD
Oxybutynin—Hypertension—Carmustine—lymphatic system cancer	0.000955	0.00215	CcSEcCtD
Oxybutynin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000954	0.00215	CcSEcCtD
Oxybutynin—Nausea—Teniposide—lymphatic system cancer	0.000953	0.00215	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000942	0.00213	CcSEcCtD
Oxybutynin—Chest pain—Carmustine—lymphatic system cancer	0.000941	0.00212	CcSEcCtD
Oxybutynin—Anxiety—Carmustine—lymphatic system cancer	0.000938	0.00212	CcSEcCtD
Oxybutynin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000928	0.00209	CcSEcCtD
Oxybutynin—Malaise—Mitoxantrone—lymphatic system cancer	0.000927	0.00209	CcSEcCtD
Oxybutynin—Convulsion—Vincristine—lymphatic system cancer	0.000915	0.00206	CcSEcCtD
Oxybutynin—Hypertension—Vincristine—lymphatic system cancer	0.000911	0.00206	CcSEcCtD
Oxybutynin—Confusional state—Carmustine—lymphatic system cancer	0.00091	0.00205	CcSEcCtD
Oxybutynin—Oedema—Carmustine—lymphatic system cancer	0.000903	0.00204	CcSEcCtD
Oxybutynin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000899	0.00203	CcSEcCtD
Oxybutynin—Cough—Mitoxantrone—lymphatic system cancer	0.000897	0.00202	CcSEcCtD
Oxybutynin—Infection—Carmustine—lymphatic system cancer	0.000897	0.00202	CcSEcCtD
Oxybutynin—Vomiting—Fludarabine—lymphatic system cancer	0.000897	0.00202	CcSEcCtD
Oxybutynin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000891	0.00201	CcSEcCtD
Oxybutynin—Rash—Fludarabine—lymphatic system cancer	0.000889	0.00201	CcSEcCtD
Oxybutynin—Dermatitis—Fludarabine—lymphatic system cancer	0.000888	0.002	CcSEcCtD
Oxybutynin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000888	0.002	CcSEcCtD
Oxybutynin—Pain—Bleomycin—lymphatic system cancer	0.000884	0.00199	CcSEcCtD
Oxybutynin—Headache—Fludarabine—lymphatic system cancer	0.000883	0.00199	CcSEcCtD
Oxybutynin—Tachycardia—Carmustine—lymphatic system cancer	0.000881	0.00199	CcSEcCtD
Oxybutynin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000875	0.00197	CcSEcCtD
Oxybutynin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000875	0.00197	CcSEcCtD
Oxybutynin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000872	0.00197	CcSEcCtD
Oxybutynin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000865	0.00195	CcSEcCtD
Oxybutynin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000862	0.00194	CcSEcCtD
Oxybutynin—Oedema—Vincristine—lymphatic system cancer	0.000862	0.00194	CcSEcCtD
Oxybutynin—Anorexia—Carmustine—lymphatic system cancer	0.00086	0.00194	CcSEcCtD
Oxybutynin—Infection—Vincristine—lymphatic system cancer	0.000856	0.00193	CcSEcCtD
Oxybutynin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000852	0.00192	CcSEcCtD
Oxybutynin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000851	0.00192	CcSEcCtD
Oxybutynin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000846	0.00191	CcSEcCtD
Oxybutynin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000845	0.00191	CcSEcCtD
Oxybutynin—Hypotension—Carmustine—lymphatic system cancer	0.000843	0.0019	CcSEcCtD
Oxybutynin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000839	0.00189	CcSEcCtD
Oxybutynin—Oedema—Mitoxantrone—lymphatic system cancer	0.000839	0.00189	CcSEcCtD
Oxybutynin—Nausea—Fludarabine—lymphatic system cancer	0.000838	0.00189	CcSEcCtD
Oxybutynin—Infection—Mitoxantrone—lymphatic system cancer	0.000834	0.00188	CcSEcCtD
Oxybutynin—Shock—Mitoxantrone—lymphatic system cancer	0.000826	0.00186	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000822	0.00186	CcSEcCtD
Oxybutynin—Urticaria—Bleomycin—lymphatic system cancer	0.000821	0.00185	CcSEcCtD
Oxybutynin—Anorexia—Vincristine—lymphatic system cancer	0.000821	0.00185	CcSEcCtD
Oxybutynin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000819	0.00185	CcSEcCtD
Oxybutynin—Insomnia—Carmustine—lymphatic system cancer	0.000816	0.00184	CcSEcCtD
Oxybutynin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000815	0.00184	CcSEcCtD
Oxybutynin—Paraesthesia—Carmustine—lymphatic system cancer	0.00081	0.00183	CcSEcCtD
Oxybutynin—Mood swings—Methotrexate—lymphatic system cancer	0.000806	0.00182	CcSEcCtD
Oxybutynin—Hypotension—Vincristine—lymphatic system cancer	0.000805	0.00182	CcSEcCtD
Oxybutynin—Somnolence—Carmustine—lymphatic system cancer	0.000802	0.00181	CcSEcCtD
Oxybutynin—Anorexia—Mitoxantrone—lymphatic system cancer	0.0008	0.0018	CcSEcCtD
Oxybutynin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000785	0.00177	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000785	0.00177	CcSEcCtD
Oxybutynin—Decreased appetite—Carmustine—lymphatic system cancer	0.000785	0.00177	CcSEcCtD
Oxybutynin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000784	0.00177	CcSEcCtD
Oxybutynin—Insomnia—Vincristine—lymphatic system cancer	0.000779	0.00176	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000779	0.00176	CcSEcCtD
Oxybutynin—Paraesthesia—Vincristine—lymphatic system cancer	0.000774	0.00175	CcSEcCtD
Oxybutynin—Constipation—Carmustine—lymphatic system cancer	0.000772	0.00174	CcSEcCtD
Oxybutynin—Pain—Carmustine—lymphatic system cancer	0.000772	0.00174	CcSEcCtD
Oxybutynin—Breast disorder—Methotrexate—lymphatic system cancer	0.000769	0.00173	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000764	0.00172	CcSEcCtD
Oxybutynin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000762	0.00172	CcSEcCtD
Oxybutynin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000753	0.0017	CcSEcCtD
Oxybutynin—Decreased appetite—Vincristine—lymphatic system cancer	0.000749	0.00169	CcSEcCtD
Oxybutynin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000746	0.00168	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000744	0.00168	CcSEcCtD
Oxybutynin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000744	0.00168	CcSEcCtD
Oxybutynin—Fatigue—Vincristine—lymphatic system cancer	0.000743	0.00168	CcSEcCtD
Oxybutynin—Asthenia—Bleomycin—lymphatic system cancer	0.000742	0.00167	CcSEcCtD
Oxybutynin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000739	0.00167	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000738	0.00167	CcSEcCtD
Oxybutynin—Pain—Vincristine—lymphatic system cancer	0.000737	0.00166	CcSEcCtD
Oxybutynin—Constipation—Vincristine—lymphatic system cancer	0.000737	0.00166	CcSEcCtD
Oxybutynin—Asthma—Methotrexate—lymphatic system cancer	0.000735	0.00166	CcSEcCtD
Oxybutynin—Pruritus—Bleomycin—lymphatic system cancer	0.000732	0.00165	CcSEcCtD
Oxybutynin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000729	0.00165	CcSEcCtD
Oxybutynin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000723	0.00163	CcSEcCtD
Oxybutynin—Constipation—Mitoxantrone—lymphatic system cancer	0.000718	0.00162	CcSEcCtD
Oxybutynin—Pain—Mitoxantrone—lymphatic system cancer	0.000718	0.00162	CcSEcCtD
Oxybutynin—Abdominal pain—Carmustine—lymphatic system cancer	0.000713	0.00161	CcSEcCtD
Oxybutynin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000705	0.00159	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000705	0.00159	CcSEcCtD
Oxybutynin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000691	0.00156	CcSEcCtD
Oxybutynin—Dysuria—Methotrexate—lymphatic system cancer	0.000687	0.00155	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000686	0.00155	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000683	0.00154	CcSEcCtD
Oxybutynin—Abdominal pain—Vincristine—lymphatic system cancer	0.000681	0.00154	CcSEcCtD
Oxybutynin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000677	0.00153	CcSEcCtD
Oxybutynin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000667	0.0015	CcSEcCtD
Oxybutynin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000665	0.0015	CcSEcCtD
Oxybutynin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000663	0.0015	CcSEcCtD
Oxybutynin—Vomiting—Bleomycin—lymphatic system cancer	0.000657	0.00148	CcSEcCtD
Oxybutynin—Drowsiness—Methotrexate—lymphatic system cancer	0.000655	0.00148	CcSEcCtD
Oxybutynin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000655	0.00148	CcSEcCtD
Oxybutynin—Infestation—Methotrexate—lymphatic system cancer	0.000655	0.00148	CcSEcCtD
Oxybutynin—Depression—Methotrexate—lymphatic system cancer	0.000654	0.00147	CcSEcCtD
Oxybutynin—Rash—Bleomycin—lymphatic system cancer	0.000652	0.00147	CcSEcCtD
Oxybutynin—Dermatitis—Bleomycin—lymphatic system cancer	0.000651	0.00147	CcSEcCtD
Oxybutynin—Asthenia—Carmustine—lymphatic system cancer	0.000648	0.00146	CcSEcCtD
Oxybutynin—Stomatitis—Methotrexate—lymphatic system cancer	0.000639	0.00144	CcSEcCtD
Oxybutynin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000637	0.00144	CcSEcCtD
Oxybutynin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000635	0.00143	CcSEcCtD
Oxybutynin—Haematuria—Methotrexate—lymphatic system cancer	0.000625	0.00141	CcSEcCtD
Oxybutynin—Epistaxis—Methotrexate—lymphatic system cancer	0.000618	0.00139	CcSEcCtD
Oxybutynin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000618	0.00139	CcSEcCtD
Oxybutynin—Asthenia—Vincristine—lymphatic system cancer	0.000618	0.00139	CcSEcCtD
Oxybutynin—Diarrhoea—Carmustine—lymphatic system cancer	0.000618	0.00139	CcSEcCtD
Oxybutynin—Nausea—Bleomycin—lymphatic system cancer	0.000614	0.00139	CcSEcCtD
Oxybutynin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000602	0.00136	CcSEcCtD
Oxybutynin—Dizziness—Carmustine—lymphatic system cancer	0.000597	0.00135	CcSEcCtD
Oxybutynin—Diarrhoea—Vincristine—lymphatic system cancer	0.000589	0.00133	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000584	0.00132	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000581	0.00131	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000577	0.0013	CcSEcCtD
Oxybutynin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000574	0.0013	CcSEcCtD
Oxybutynin—Vomiting—Carmustine—lymphatic system cancer	0.000574	0.00129	CcSEcCtD
Oxybutynin—Dizziness—Vincristine—lymphatic system cancer	0.00057	0.00129	CcSEcCtD
Oxybutynin—Rash—Carmustine—lymphatic system cancer	0.000569	0.00128	CcSEcCtD
Oxybutynin—Dermatitis—Carmustine—lymphatic system cancer	0.000569	0.00128	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—lymphatic system cancer	0.000567	0.00128	CcSEcCtD
Oxybutynin—Headache—Carmustine—lymphatic system cancer	0.000565	0.00128	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—lymphatic system cancer	0.00055	0.00124	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—lymphatic system cancer	0.000549	0.00124	CcSEcCtD
Oxybutynin—Vomiting—Vincristine—lymphatic system cancer	0.000548	0.00124	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000546	0.00123	CcSEcCtD
Oxybutynin—Rash—Vincristine—lymphatic system cancer	0.000543	0.00123	CcSEcCtD
Oxybutynin—Dermatitis—Vincristine—lymphatic system cancer	0.000543	0.00122	CcSEcCtD
Oxybutynin—Headache—Vincristine—lymphatic system cancer	0.00054	0.00122	CcSEcCtD
Oxybutynin—Nausea—Carmustine—lymphatic system cancer	0.000536	0.00121	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—lymphatic system cancer	0.000534	0.0012	CcSEcCtD
Oxybutynin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000533	0.0012	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00053	0.0012	CcSEcCtD
Oxybutynin—Rash—Mitoxantrone—lymphatic system cancer	0.000529	0.00119	CcSEcCtD
Oxybutynin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000529	0.00119	CcSEcCtD
Oxybutynin—Headache—Mitoxantrone—lymphatic system cancer	0.000526	0.00119	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—lymphatic system cancer	0.000516	0.00116	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—lymphatic system cancer	0.000512	0.00116	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—lymphatic system cancer	0.000512	0.00116	CcSEcCtD
Oxybutynin—Nausea—Vincristine—lymphatic system cancer	0.000512	0.00115	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000502	0.00113	CcSEcCtD
Oxybutynin—Nausea—Mitoxantrone—lymphatic system cancer	0.000498	0.00112	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—lymphatic system cancer	0.000495	0.00112	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—lymphatic system cancer	0.000483	0.00109	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000475	0.00107	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—lymphatic system cancer	0.000462	0.00104	CcSEcCtD
Oxybutynin—Cough—Methotrexate—lymphatic system cancer	0.000447	0.00101	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—lymphatic system cancer	0.000444	0.001	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—lymphatic system cancer	0.000436	0.000984	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—lymphatic system cancer	0.000436	0.000984	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000433	0.000977	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—lymphatic system cancer	0.000431	0.000972	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—lymphatic system cancer	0.000422	0.000951	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000418	0.000943	CcSEcCtD
Oxybutynin—Infection—Methotrexate—lymphatic system cancer	0.000415	0.000937	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00041	0.000925	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—lymphatic system cancer	0.000406	0.000916	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—lymphatic system cancer	0.000398	0.000899	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—lymphatic system cancer	0.000391	0.000881	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000381	0.000859	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—lymphatic system cancer	0.000378	0.000853	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000375	0.000847	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—lymphatic system cancer	0.000372	0.000839	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000368	0.00083	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000363	0.00082	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000361	0.000814	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—lymphatic system cancer	0.00036	0.000813	CcSEcCtD
Oxybutynin—Pain—Methotrexate—lymphatic system cancer	0.000357	0.000807	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000344	0.000777	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000342	0.000771	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—lymphatic system cancer	0.000332	0.000749	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—lymphatic system cancer	0.00033	0.000746	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000308	0.000695	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—lymphatic system cancer	0.0003	0.000677	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—lymphatic system cancer	0.000296	0.000667	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000286	0.000645	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—lymphatic system cancer	0.000276	0.000624	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—lymphatic system cancer	0.000266	0.0006	CcSEcCtD
Oxybutynin—Rash—Methotrexate—lymphatic system cancer	0.000264	0.000595	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—lymphatic system cancer	0.000263	0.000594	CcSEcCtD
Oxybutynin—Headache—Methotrexate—lymphatic system cancer	0.000262	0.000591	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—lymphatic system cancer	0.000248	0.00056	CcSEcCtD
